Saturday 9 August 2008

New Hope for Old Chemotherapy?

While the vast majority of cancer research focuses on new therapeutic approaches, recent research on an unrelated topic has revealed new potential for old chemotherapy techniques. Anti-aging research by Valter Longo and colleagues at the University of Southern California chanced upon the idea while studying the effects differential stress resistance brought on by fasting. The groundbreaking study, published recently by Proceedings of the National Academy of Sciences, showed that fasting before chemotherapy has the potential to protect healthy cells from the deleterious effects of broad-spectrum chemotherapy, while cancer cells remain susceptible. Expert Opinion author Antonio Russo has reviewed this research and the potential for further development of this concept in a recent article in Expert Opinion on Therapeutic Targets.

1. Click Here to Receive a Free Token to Download this Paper

and then

2. Click Here to Take You to the Paper

Saturday 2 August 2008

Expert Opinion 2007 Impact Factors

The 2007 ISI Impact Factors have just been released, and Expert Opinion has had a good year. Expert Opinion on Emerging Drugs has now received its first Impact Factor, emerging with a strong first showing of 2.725. Expert Opinion on Therapeutic Targets enjoyed the greatest increase from 2006, jumping from 2.662 to 3.333, while Expert Opinion on Investigational Drugs continues to have the highest Impact Factor and total citations among the Expert Opinion journals.

Expert Opinion on Investigational Drugs: 3.667 (up from 3.174)
Expert Opinion on Therapeutic Targets: 3.333 (up from 2.662)
Expert Opinion on Biological Therapy: 2.815 (up from 2.705)
Expert Opinion on Emerging Drugs: 2.725 (first Impact factor for EOED)
Expert Opinion on Pharmacotherapy: 1.703
Expert Opinion on Therapeutic Patents: 1.589 (up from 1.488)